NCT06471062

Brief Summary

Transit-time flowmetry (TTFM) allows grafts quality control during coronary artery bypass surgery by measuring the flow volume through them. To date, many studies have deeply studied the predictive role on the graft outcomes of the various flowmetry-derived parameters. One of the least investigated aspects, however, is the mutual influence that two newly realized grafts can have. This possibility would be related to the presence of a more or less developed collateral circulation between the bypassed territories. The purpose of this study is to assess whether a graft for a territory different than that provided by the left anterior descending artery (LAD) may affect the functionality (measured through flowmetry) of the left internal mammary artery - LAD graft.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
135

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2025

Completed
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

6 months

First QC Date

May 28, 2024

Last Update Submit

November 26, 2024

Conditions

Keywords

coronary artery bypassTransit Time FlowmetryIntraoperative epicardial high-frequency ultrasound (HFUS)Coronary anastomosis patency

Outcome Measures

Primary Outcomes (1)

  • LIMA>LAD Pulsatility index (PI) modification

    The primary aim of this study is to assess whether a graft for a non-LAD coronary target modifies the performance (measured by flowmetry) of the flow in the LIMA\>LAD graft. PI is expressed by the ratio of the flow volume amplitude and mean flow volume, both quantified by a flowmeter (ml/min / ml/min). An ideal value would be \< 3

    During the surgery, out of cardiopulmonary bypass

Secondary Outcomes (5)

  • LIMA>LAD mean flow change

    During surgery, before and after transient occlusion of the other grafts for non-LAD coronary targets

  • LIMA>LAD Diastolic filling (%DF) change

    During surgery,before and after transient occlusion of the other grafts for non-LAD coronary targets.

  • variation of Diastolic filling (%DF) on the right coronary

    During surgery,before and after transient occlusion of the other grafts for non-LAD coronary targets.

  • LIMA>LAD % Backward flow (BF) change

    During surgery, before and after transient occlusion of the other grafts for non-LAD coronary targets.

  • mean flow, Pulsatility Index, Diastolic filling (%DF) and Diastolic filling (%DF) in the non-LAD grafts

    During surgery, before and after transient occlusion of the LIMA>LAD graft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.

You may qualify if:

  • age \> 18 years;
  • informed consent acquired and registered;
  • patients who undergo coronary artery bypass grafting (with or without cardiopulmonary bypass);
  • patients with stable angina, unstable angina or acute coronary syndrome without elevation of the ST tract (NSTEMI)

You may not qualify if:

  • patients unable to give informed consent;
  • patients undergoing emergency surgery;
  • patients in unstable haemodynamic conditions or in need of pharmacological or mechanical support;
  • patients undergoing combined surgery;
  • patients undergoing single aortocoronary bypass surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Gemelli IRCCS

Roma, Italy

Location

MeSH Terms

Conditions

Coronary Artery DiseaseCoronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • federico cammertoni

    Fondazione Policlinico Gemelli IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

May 28, 2024

First Posted

June 24, 2024

Study Start

November 20, 2024

Primary Completion

May 20, 2025

Study Completion

October 20, 2025

Last Updated

November 27, 2024

Record last verified: 2024-11

Locations